SPONSOR
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Moderate to Severe Acute Postoperative Pain, Healthy Participants, Sepsis.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
How many clinical trials has Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Moderate to Severe Acute Postoperative Pain, Healthy Participants, Sepsis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. research focus on?
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. clinical trials span Moderate to Severe Acute Postoperative Pain, Healthy Participants, Sepsis. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. clinical trial?
To participate in a Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
NCT07147049 Phase 2
Recruiting
Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery
Moderate to Severe Acute Postoperative Pain
NCT06912295 Phase 1
Recruiting
Assess the Safety, Tolerability, and Pharmacokinetics of HL-1186 in Healthy Participants
Healthy Participants
NCT07413094 Phase 2
Recruiting
Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS
Sepsis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology